Serum metabonomics study of adenine-induced chronic renal failure in rats by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry

References

• Cantley LC. (2002). The phosphoinositide 3-kinase pathway. Science 296:1655–1657.
   PubMed Web of Science ®Google Scholar
• Chen M, Su M, Zhao L, Jiang J, Liu P, Cheng J, Lai Y, Liu Y, Jia W. (2006). Metabonomic study of aristolochic acid-induced nephrotoxicity in rats. J Proteome Res 5:995–1002.
   PubMed Web of Science ®Google Scholar
• Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, Gilbertson D, Grimm R, Liu J, Louis T, Manning W, Matas A, McBean M, Murray A, St Peter W, Xue J, Fan Q, Guo H, Li S, Li S, Roberts T, Snyder J, Solid C, Wang C, Weinhandl E, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Johnson R, Sheets D, Forrest B, Berrini D, Constantini E, Everson S, Frederick P, Eggers P, Agodoa L; United States Renal Data System. (2005). Excerpts from the United States Renal Data System 2004 annual data report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis 45:A5–7, S1.
   Google Scholar
• Constantinou MA, Papakonstantinou E and Spraul M. (2005). 1H NMR-based metabonomics for the diagnosis of inborn errors of metabolism in urine. Anal Chim Acta 511:303–312.
   Google Scholar
• Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. (2003). Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41:1–12.
   PubMed Web of Science ®Google Scholar
• Desmond O, and Russell M-S. (2006). High-throughput bioanalysis with simultaneous acquisition of metabolic route data using ultra performance liquid chromatography coupled with time-of-flight mass spectrometry. Anal Bioanal Chem 385:114–121.
   Google Scholar
• Downes CP, Gray A, Lucocq JM. (2005). Probing phosphoinositide functions in signaling and membrane trafficking. Trends Cell Biol 15:259–268.
   PubMed Web of Science ®Google Scholar
• Dunn WB, Broadhurst DI, Deepak SM, Buch MH, McDowell G, Spasic I, Ellis DI, Brooks N, Kell DB and Neyses L. (2007). Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate. Metabolomics 3:413–426.
   Web of Science ®Google Scholar
• Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H. (1992). ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41:1520–1527.
   PubMed Web of Science ®Google Scholar
• Griffin JL, Bollard ME. (2004). Metabonomics: Its potential as a tool in toxicology for safety assessment and data integration. Curr Drug Metab 5:389–398.
   PubMed Web of Science ®Google Scholar
• Jackson SN, Wang HY, Woods AS, Ugarov M, Egan T, Schultz JA. (2005). Direct tissue analysis of phospholipids in rat brain using MALDI-TOFMS and MALDI-ion mobility-TOFMS. J Am Soc Mass Spectrom 16:133–138.
   PubMed Web of Science ®Google Scholar
• Jia LW, Chen J, Yin PY, Lu X and Xu GW. (2008). Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry. Metabolomics 4:183–189.
   Web of Science ®Google Scholar
• Johnson KA, Plumb R. (2005). Investigating the human metabolism of acetaminophen using UPLC and exact mass oa-TOF MS. J Pharm Biomed Anal 39:805–810.
   PubMed Web of Science ®Google Scholar
• Kellert M, Wagner S, Lutz U, Lutz WK. (2008). Biomarkers of furan exposure by metabolic profiling of rat urine with liquid chromatography-tandem mass spectrometry and principal component analysis. Chem Res Toxicol 21:761–768.
   PubMed Web of Science ®Google Scholar
• Keun HC, Beckonert O, Griffin JL, Richter C, Moskau D, Lindon JC, Nicholson JK. (2002). Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. Anal Chem 74:4588–4593.
   PubMed Web of Science ®Google Scholar
• Khandelwal P, Beyer CE, Lin Q, McGonigle P, Schechter LE, Bach AC 2nd. (2004). Nanoprobe NMR spectroscopy and in vivo microdialysis: New analytical methods to study brain neurochemistry. J Neurosci Methods 133:181–189.
   Google Scholar
• Kuhara T. (2005). Gas chromatographic-mass spectrometric urinary metabolome analysis to study mutations of inborn errors of metabolism. Mass Spectrom Rev 24:814–827.
   PubMed Web of Science ®Google Scholar
• Lemmon MA. (2003). Phosphoinositide recognition domains. Traffic 4:201–213.
   PubMed Web of Science ®Google Scholar
• Li F, Lu X, Liu H, Liu M, Xiong Z. (2007). A pharmaco-metabonomic study on the therapeutic basis and metabolic effects of Epimedium brevicornum Maxim. on hydrocortisone-induced rat using UPLC-MS. Biomed Chromatogr 21:397–405.
   PubMed Web of Science ®Google Scholar
• Lindon JC, Holmes E, Nicholson JK. (2006). Metabonomics techniques and applications to pharmaceutical research & development. Pharm Res 23:1075–1088.
   PubMed Web of Science ®Google Scholar
• Lindon JC, Holmes E, Nicholson JK. (2007). Metabonomics in pharmaceutical R&D. FEBS J 274:1140–1151.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Del Vecchio L, Pozzoni P, Manzoni C. (2006). Nephrology: Main advances in the last 40 years. J Nephrol 19:6–11.
   PubMed Web of Science ®Google Scholar
• Lynch JJ, Ferro TJ, Blumenstock FA, Brockenauer AM, Malik AB. (1990). Increased endothelial albumin permeability mediated by protein kinase C activation. J Clin Invest 85:1991–1998.
   PubMed Web of Science ®Google Scholar
• Nangaku M. (2004). Mechanisms of tubulointerstitial injury in the kidney: Final common pathways to end-stage renal failure. Intern Med 43:9–17.
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Lindon JC, Holmes E. (1999). ‘Metabonomics’: Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181–1189.
   PubMed Web of Science ®Google Scholar
• Plumb RS, Granger JH, Stumpf CL, Johnson KA, Smith BW, Gaulitz S, Wilson ID, Castro-Perez J. (2005). A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: Application to age, gender and diurnal variation in normal/Zucker obese rats and black, white and nude mice. Analyst 130:844–849.
   PubMed Web of Science ®Google Scholar
• Rhee SG. (2001). Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 70:281–312.
   PubMed Web of Science ®Google Scholar
• Robertson DG, Reily MD, Baker JD. (2007). Metabonomics in pharmaceutical discovery and development. J Proteome Res 6:526–539.
   PubMed Web of Science ®Google Scholar
• Wenk MR. (2005). The emerging field of lipidomics. Nat Rev Drug Discov 4:594–610.
   PubMed Web of Science ®Google Scholar
• Wilson ID, Nicholson JK, Castro-Perez J, Granger JH, Johnson KA, Smith BW, Plumb RS. (2005). High resolution “ultra performance” liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J Proteome Res 4:591–598.
   PubMed Web of Science ®Google Scholar
• Wolf G. (2006). Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int 70:1914–1919.
   PubMed Web of Science ®Google Scholar
• Yang J, Zhao X, Liu X, Wang C, Gao P, Wang J, Li L, Gu J, Yang S, Xu G. (2006). High performance liquid chromatography-mass spectrometry for metabonomics: Potential biomarkers for acute deterioration of liver function in chronic hepatitis B. J Proteome Res 5:554–561.
   PubMed Web of Science ®Google Scholar
• Yin P, Zhao X, Li Q, Wang J, Li J, Xu G. (2006). Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS). J Proteome Res 5:2135–2143.
   PubMed Web of Science ®Google Scholar
• Yokozawa T, Zheng PD, Oura H, Koizumi F. (1986). Animal model of adenine-induced chronic renal failure in rats. Nephron 44:230–234.
   PubMed Web of Science ®Google Scholar
• Yu HT. (2003). Progression of chronic renal failure. Arch Intern Med 163:1417–1429.
   PubMed Web of Science ®Google Scholar
• Zoccali C. (2006). Traditional and emerging cardiovascular and renal risk factors: An epidemiologic perspective. Kidney Int 70:26–33.
   PubMed Web of Science ®Google Scholar